
    
      A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the
      Safety and Efficacy of IDP-122 Lotion (0.01% halobetasol propionate) to UltravateÂ®
      (halobetasol propionate) Cream, 0.05% in the Treatment of Plaque Psoriasis.
    
  